Ptc Therapeutics (PTCT) Other Non Operating Income (2012 - 2026)

Ptc Therapeutics' Other Non Operating Income history runs 15 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 125.52% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at -$10.2 million (down 652.37% YoY), while the FY2025 annual figure was -$18.1 million, down 376.38% from the prior year.
• Other Non Operating Income was $1.6 million for Q1 2026 at Ptc Therapeutics, up from -$12.5 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $35.1 million in Q4 2022 to a low of -$128.7 million in Q4 2023.
• Historically, Other Non Operating Income has averaged -$11.6 million across 5 years, with a median of -$2.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income sank 1183.82% in 2022, then soared 447.33% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $35.1 million in 2022, then slumped by 466.24% to -$128.7 million in 2023, then surged by 106.88% to $8.8 million in 2024, then slumped by 241.76% to -$12.5 million in 2025, then soared by 112.82% to $1.6 million in 2026.
• The last three Other Non Operating Income figures came in at $1.6 million (Q1 2026), -$12.5 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.